ABSTRACT
OBJECTIVE: Fetoscopic laser photocoagulation (FLP) is a well-established treatment for twin-twin transfusion syndrome (TTTS) between 16 and 26 weeks' gestation. High-quality evidence and guidelines regarding the optimal clinical management of very early (prior to 16 weeks), early (between 16 and 18 weeks) and late (after 26 weeks) TTTS are lacking. The aim of this study was to construct a structured expert-based clinical consensus for the management of early and late TTTS. METHODS: A Delphi procedure was conducted among an international panel of experts. Participants were chosen based on their clinical expertise, affiliation and relevant publications. A four-round Delphi survey was conducted using an online platform and responses were collected anonymously. In the first round, a core group of experts was asked to answer open-ended questions regarding the indications, timing and modes of treatment for early and late TTTS. In the second and third rounds, participants were asked to grade each statement on a Likert scale (1, completely disagree; 5, completely agree) and to add any suggestions or modifications. At the end of each round, the median score for each statement was calculated. Statements with a median grade of 5 without suggestions for change were accepted as the consensus. Statements with a median grade of 3 or less were excluded from the Delphi process. Statements with a median grade of 4 were modified according to suggestions and reconsidered in the next round. In the last round, participants were asked to agree or disagree with the statements, and those with more than 70% agreement without suggestions for change were considered the consensus. RESULTS: A total of 122 experts met the inclusion criteria and were invited to participate, of whom 53 (43.4%) agreed to take part in the study. Of those, 75.5% completed all four rounds. A consensus on the optimal management of early and late TTTS was obtained. FLP can be offered as early as 15 weeks' gestation for selected cases, and can be considered up to 28 weeks. Between 16 and 18 weeks, management should be tailored according to Doppler findings. CONCLUSIONS: A consensus-based treatment protocol for early and late TTTS was agreed upon by a panel of experts. This protocol should be modified at the discretion of the operator, according to their experience and the specific demands of each case. This should advance the quality of future studies, guide clinical practice and improve patient care. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
Subject(s)
Fetofetal Transfusion , Gynecology , Female , Pregnancy , Humans , Consensus , Delphi Technique , Fetofetal Transfusion/diagnostic imaging , Fetofetal Transfusion/surgery , FetoscopySubject(s)
Fetal Diseases/surgery , Meningomyelocele/surgery , Perioperative Care , Adult , Anesthesia, Obstetrical , Female , Humans , Infant, Newborn , Male , PregnancyABSTRACT
INTRODUCTION: The aim of this study is to evaluate the prevalence of veno-venous (VV) anastomoses in a large cohort of monochorionic (MC) twin placentas with twin-twin transfusion syndrome (TTTS) compared to a control group of MC placentas without TTTS. METHODS: All TTTS placentas not treated with fetoscopic laser surgery (TTTS group) and examined at five international fetal therapy centers were included in this study and compared with a control group of MC placentas without TTTS (non-TTTS group). MC placentas were routinely injected with colored dye. We recorded the presence of VV and arterio-arterial (AA) anastomoses. RESULTS: A total of 414 MC placentas were included in this study (TTTS group, n = 106; non-TTTS group, n = 308). The prevalence of VV anastomoses was significantly higher in the TTTS group than in the non-TTTS group, 36% (38/106) and 25% (78/308), respectively (p = .04; odds ratio (OR) 1.65; 95% confidence interval (CI): 1.03-2.64). In the subgroup of MC placentas without AA anastomoses, the prevalence of VV anastomoses in the TTTS group and non-TTTS group was 32% (18/57) and 8% (2/25), respectively (p = .03; OR: 5.31; 95% CI: 1.13-24.98). DISCUSSION: VV anastomoses are detected more frequently in TTTS placentas than in MC placentas without TTTS and may thus play a role in the development of TTTS.
Subject(s)
Fetofetal Transfusion/epidemiology , Vascular Fistula/epidemiology , Female , Fetofetal Transfusion/surgery , Fetoscopy , Humans , Male , Pregnancy , Prevalence , Twins, Monozygotic , Vascular Fistula/surgeryABSTRACT
OBJECTIVE: To determine, by expert consensus, the essential substeps of fetoscopic laser surgery (FLS) for twin-twin transfusion syndrome (TTTS) that could be used to create an authority-based curriculum for training in this procedure among fetal medicine specialists. METHODS: A Delphi survey was conducted among an international panel of experts (n = 98) in FLS. Experts rated the substeps of FLS on a five-point Likert-type scale to indicate whether they considered them to be essential, and were able to comment on each substep, using a dedicated online platform accessed by the invited tertiary care facilities that specialize in fetal therapy. Responses were returned to the panel until consensus was reached (Cronbach's α ≥ 0.80). All substeps that were rated ≥ 4 by 80% of the experts were included in the evaluation instrument. RESULTS: After the first iteration of the Delphi procedure, a response rate of 74% (73/98) was reached, and in the second and third iterations response rates of 90% (66/73) and 81% (59/73) were reached, respectively. Among a total of 81 substeps rated in the first round, 21 substeps had to be re-rated in the second round. Finally, from the initial list of substeps, 55 were agreed by experts to be essential. In the third round, the 18 categorized substeps were ranked in order of importance, with 'coagulation of all anastomoses that cross the equator' and 'determination of fetoscope insertion site' as the most important. CONCLUSIONS: A total of 55 substeps of FLS for TTTS were defined by a panel of experts to be essential in the procedure. This list is the first authority-based evidence to be used in the development of a final training model for future fetal surgeons.
Subject(s)
Delphi Technique , Fetofetal Transfusion/surgery , Fetoscopy/methods , Laser Therapy/methods , Computer Simulation , Consensus , Female , Fetoscopy/education , Humans , Pregnancy , Surveys and Questionnaires , Tertiary Care CentersABSTRACT
Epithelial ovarian cancer (EOC) during pregnancy is a rare condition. The diagnosis and treatment strategies are therefore not well defined. The evidence is scarce and limited to small case reports or case series. In this review we describe the safety, utility and limitations of each diagnostic tool and surgical procedure in pregnant women with ovarian cancer. We also discuss the role of chemotherapy for ovarian cancer during pregnancy. Finally, we delineate different strategies of treatment according to the stage of the disease at diagnosis and gestational age. Due to the complexity of the management of EOC during pregnancy, patients should be referred to specialized centers. Gestational age at diagnosis, the initial surgical procedure, disease stage and patient's preferences are the key factors in the decision-making process to establish the best treatment strategy for each individual case (AU)
Subject(s)
Humans , Female , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/radiotherapy , Pregnant Women/psychology , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/geneticsABSTRACT
Epithelial ovarian cancer (EOC) during pregnancy is a rare condition. The diagnosis and treatment strategies are therefore not well defined. The evidence is scarce and limited to small case reports or case series. In this review we describe the safety, utility and limitations of each diagnostic tool and surgical procedure in pregnant women with ovarian cancer. We also discuss the role of chemotherapy for ovarian cancer during pregnancy. Finally, we delineate different strategies of treatment according to the stage of the disease at diagnosis and gestational age. Due to the complexity of the management of EOC during pregnancy, patients should be referred to specialized centers. Gestational age at diagnosis, the initial surgical procedure, disease stage and patient's preferences are the key factors in the decision-making process to establish the best treatment strategy for each individual case.
Subject(s)
Neoplasms, Glandular and Epithelial/therapy , Ovarian Neoplasms/therapy , Pregnancy Complications, Neoplastic/therapy , Carcinoma, Ovarian Epithelial , Disease Progression , Female , Humans , Medical Oncology/legislation & jurisprudence , Medical Oncology/methods , Medical Oncology/trends , Models, Biological , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/pathology , Practice Guidelines as Topic , PregnancyABSTRACT
OBJECTIVE: Congenital megalourethra is a rare urogenital malformation characterized by dilation and elongation of the penile urethra associated with absence or hypoplasia of the corpora spongiosa and cavernosa. Postnatal complications include voiding and erectile dysfunction as well as renal insufficiency and pulmonary hypoplasia. To date, only a few prenatally diagnosed cases have been reported. We report on 10 cases diagnosed prenatally and their postnatal/autopsy findings. METHODS: The study involved retrospective chart review of all cases diagnosed antenatally in three tertiary care centers over 5 years. Antenatal ultrasound images and medical records from obstetrics, genetics, urology and nephrology were reviewed. RESULTS: Ten fetuses with megalourethra were identified at a median gestational age of 19 (range, 13-24) weeks and all were confirmed postnatally or at autopsy. Three pregnancies were terminated and seven continued. All cases presented with a distended bladder and megalourethra and all cases had normal karyotype. Of seven liveborn babies, one died neonatally of pulmonary hypoplasia. All six infants alive at the time of writing had a dysfunctional urethra and three suffered from impaired or end-stage renal disease. Associated anomalies were found in half of the cases. CONCLUSION: Congenital megalourethra is caused by abnormal development or hypoplasia of the penile erectile tissue, secondary to distal urethral obstruction. When the amniotic fluid volume is normal, survival is possible. However, all liveborn infants have voiding and renal dysfunction and sexual dysfunction is expected. Megalourethra should be considered in all male fetuses presenting prenatally with megacystis and detailed fetal ultrasonography should look for an elongated and/or distended phallic structure as well as any associated anomalies.
Subject(s)
Penis/diagnostic imaging , Urethra/diagnostic imaging , Autopsy , Female , Gestational Age , Humans , Male , Penis/abnormalities , Penis/pathology , Pregnancy , Pregnancy Outcome , Retrospective Studies , Ultrasonography, Prenatal , Urethra/abnormalities , Urethra/pathologyABSTRACT
OBJECTIVES: To establish normal fetal values for the mechanical PR interval by pulsed-wave Doppler at 16-36 weeks of gestation, and to evaluate the influence of fetal heart rate (FHR), gestational age (GA) and fetal sex. METHODS: Fetal mechanical PR intervals were evaluated prospectively by obstetric ultrasound examination. Healthy mothers with sonographically normal fetuses from singleton pregnancies were included. Mechanical PR intervals were measured from simultaneous mitral and aortic Doppler waveforms, from the onset of left atrial contraction (mitral A-wave) to the onset of left ventricular ejection (aortic pulse wave). Simple and multiple linear regression analyses were performed to examine the correlation between PR interval and GA, FHR and fetal sex. RESULTS: We evaluated 336 fetuses at 16-36 weeks. The mean +/- SD FHR was 143.4 +/- 8.3 beats per min (bpm). The PR intervals had a typical Gaussian distribution with a mean +/- SD of 122.4 +/- 10.3 ms. Robust linear regression showed that the PR increased by about 0.40 ms (95% CI, 0.22-0.58) per gestational week (P < 0.001), and this relationship remained after adjustment for FHR and fetal sex. PR intervals diminished by 1.4 (95% CI, 0.75 to 2.0) ms for each 5 bpm increase in FHR (P < 0.001), independently of GA and fetal sex. No fetal sex differences were observed. CONCLUSIONS: We provide normal fetal values for the mechanical PR interval at 16-36 weeks of gestation. Mechanical PR intervals in normal fetuses are influenced by GA and FHR independently, and both variables should be taken into account when evaluating fetuses at risk for congenital heart block.
Subject(s)
Fetal Heart/diagnostic imaging , Heart Conduction System/diagnostic imaging , Heart Rate, Fetal/physiology , Ultrasonography, Prenatal/methods , Female , Fetal Heart/physiology , Gestational Age , Heart Conduction System/embryology , Humans , Pregnancy , Prospective Studies , Reference Values , Sex Factors , Ultrasonography, DopplerABSTRACT
Oxaliplatin has been approved for adjuvant treatment of colorectal cancer. Toxicity induced by oxaliplatin is moderate and manageable, but some isolated cases of severe pulmonary toxicity associated to oxaliplatin have been reported. Two fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis are reported here (AU)
No disponible
Subject(s)
Humans , Male , Female , Aged , Pulmonary Fibrosis/chemically induced , Organoplatinum Compounds/adverse effects , Lung Diseases, Interstitial/chemically induced , Antineoplastic Agents, Alkylating/adverse effects , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Pulmonary Fibrosis/pathology , Pulmonary Fibrosis , Organoplatinum Compounds/administration & dosage , Lung Diseases, Interstitial/pathology , Lung Diseases, Interstitial , Combined Modality Therapy/methods , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Fluorouracil/therapeutic useABSTRACT
OBJECTIVE: To evaluate the effect of early versus delayed feeding after caesarean section on the woman's satisfaction. DESIGN: Randomised, controlled trial. SETTING: Tertiary care hospital. POPULATION: Healthy pregnant women were enrolled for the study during antenatal care visits. METHODS: Uncomplicated singleton pregnancies undergoing a planned or intrapartum caesarean section performed under regional anaesthesia were randomly assigned to either (1) a 'delayed feeding' group who started oral fluids 4 hours after surgery with diet introduced at 24 hours; or (2) an 'early feeding' group who were offered a regular diet within the first 8 hours. MAIN OUTCOME MEASURES: Primary outcome was the woman's satisfaction measured with a visual analogue scale (VAS) before their hospital discharge. The secondary outcomes were: pain, anorexia, abdominal distension, persistent nausea and/or vomiting, time to the first bowel movement and passage of flatus. RESULTS: Two hundred women were recruited, with 103 randomised to delayed feeding and 97 to early feeding. The woman's satisfaction (mean VAS +/- SD) was similar in both groups; 73 +/- 17 mm in the delayed feeding group and 77 +/- 13 mm in the early feeding group (P= 0.12). A statistically significant difference was observed in mean postoperative pain: 29 +/- 13 mm in the delayed feeding group versus 24 +/- 11 mm in the early feeding group (P= 0.008). No other significant differences in postoperative variables were recorded, and there were no major postoperative complications observed in either group. CONCLUSION: Early feeding after uncomplicated caesarean in low-risk women is equivalent in terms of the woman's satisfaction and the reduced perceived pain.
Subject(s)
Cesarean Section/psychology , Eating/psychology , Patient Satisfaction , Postoperative Care/methods , Adult , Female , Humans , Maternal Age , Pain, Postoperative/etiology , Postoperative Care/psychology , Time FactorsABSTRACT
El coriocarcinoma es un tumor poco frecuente. El diagnóstico temprano es difícil. Presentamos un caso de coriocarcinoma que debuta con síntomas no ginecológicos. En el momento del diagnóstico presenta metástasis pulmonares y cerebrales. A pesar de la buena respuesta inicial al tratamiento la paciente fallece por complicaciones secundarias. No debemos olvidar la posibilidad de este tumor ante una mujer joven con síntomas y/o signos neurológicos o respiratorios que no responden al tratamiento inicial
Choriocarcinoma are unusual tumors. Early diagnosis is difficult. We present a case of choriocarcinoma, the first symptoms of which were non-gynaecological. At the time of diagnosis both pulmonary and cerebral metastasis were confirmed. In spite of the good initial therapeutic response, the patient died due to secondary complications. We should not forget the possibility of this tumor in a young patient with neurological and respiratory symptoms that do not respond to initial treatment
Subject(s)
Female , Adult , Humans , Choriocarcinoma, Non-gestational/diagnosis , Dyspnea/etiology , Early DiagnosisABSTRACT
Este es el caso de un varón afecto de un probable melanoma meníngeo que debuta con una paraplejia por compresión medular. El melanoma maligno de localización en el sistema nervioso central varía en las características citológicas mucho más que en otros lugares. En ocasiones puede resultar muy dificultosa e incluso imposible su precisa clasificación histológica. Paralelamente se revisará el tratamiento bioquimioterápico en este tipo de tumores (AU)
Subject(s)
Male , Middle Aged , Humans , Melanoma/complications , Melanoma/diagnosis , Paraplegia/complications , Paraplegia/diagnosis , Interferons/administration & dosage , Immunotherapy/methods , Immunotherapy/standards , Immunotherapy , Meningeal Neoplasms/complications , Meningeal Neoplasms/diagnosis , Meningeal Neoplasms/therapy , Central Nervous System/pathology , Hypesthesia/complications , Hypesthesia/diagnosis , Laminectomy/methods , Laminectomy/standardsABSTRACT
OBJECTIVES: To evaluate the association between absence of nasal bone on ultrasound and Down syndrome in fetuses at 11-14 weeks of pregnancy. METHODS: One hundred and ninety-four consecutive fetuses from singleton pregnancies undergoing chorionic villi sampling (CVS) were evaluated by transabdominal ultrasound. A sagittal view of the fetal face was obtained and the absence or presence of nasal bone was recorded and correlated with the fetal karyotype. RESULTS: A successful view of the fetal profile was possible in 183 of 194 (94%) fetuses. The nasal bone was absent in three of five fetuses with Down syndrome, and in one of 175 (0.6%) chromosomally normal fetuses. CONCLUSION: Absence of nasal bone by first trimester ultrasound was significantly associated with Down syndrome. When a proper view of the fetal face was obtained, the nasal bone was visible in more than 99% of karyotypically normal fetuses.
Subject(s)
Biomarkers , Down Syndrome/diagnostic imaging , Nasal Bone/diagnostic imaging , Nasal Bone/embryology , Ultrasonography, Prenatal , Adult , Aneuploidy , Crown-Rump Length , False Positive Reactions , Female , Humans , Karyotyping , Maternal Age , Nasal Bone/abnormalities , Pregnancy , Pregnancy Trimester, First , Pregnancy, High-RiskABSTRACT
Propósito: Descripción de las características clínicas de la hipersensibilidad al Carboplatino (CBDCA).Material y métodos: Presentamos cuatro casos de hipersensibilidad al CBDCA recogidos a lo largo de 14 meses entre 143 pacientes tratados con esta medicación. Resultados: Todas habían recibido tratamiento previo con CBDCA sin problemas y la reacción apareció tras uno o más ciclos. Todas presentaron ansiedad, tres prurito, una exantema, otra eritema, una tos, otra disnea, otra hipotensión y otra dolor torácico. En dos de ellas inicialmente la reacción se achacó al paclitaxel. Conclusión: Una reacción alérgica al CBDCA puede comprometer la vida del paciente por lo que es importante conocer los signos y síntomas de la misma para tratarla y evitar reexposiciones graves (AU)
Subject(s)
Aged , Female , Middle Aged , Humans , Carboplatin/adverse effects , Drug HypersensitivityABSTRACT
Objetivo: Describir los resultados del tratamiento anti-agregante plaquetario en un grupo de pacientes con auto-anticuerpos y antecedentes de aborto recurrente (AR) y/o retardo de crecimiento intrauterino (RCIU). Material y Métodos: Diecisiete pacientes que consultaron por AR y/o RCIU, mala historia obstétrica o antecedentes de VDRL falso positivo, en cuyo estudio inmunológico se detectaron autoanticuerpos, constituyen el material del presente trabajo. A las pacientes que tenían como antecedente un RCIU, una vez descartados todos los cuadros clínicos que pudieran ocasionarlo, se les efectuó determinación de anticuerpos. Las parejas que consultaban por AR eran sometidas a estudio para descartar un factor uterino, infeccioso, endocrinológico, metabólico, genético, innmunológico y espermático. En algunas pacientes se realizó una laparoscopia para descartar endometriosis. Todas las pacientes fueron tratadas con Acido Acetilsalicílico (AAS) 80 mg diarios, a partir del momento de la detección de autoanticuerpos. A una sola paciente se le administró además heparina subcutánea durante dos embarazos. Resultados: De las diecisiete pacientes en las que se detectaron autoanticuerpos, catorce embarazaron, algunas de ellas en más de una oportunidad, sumando un total de 24 embarazos. De ellos, 5 concluyeron en aborto espontáneo y dieciocho concluyeron en el tercer trimestre con recién nacido vivo. De éstos, siete presentaron un crecimiento fetal normal, mientras que los once restantes desarrollaron RCIU. La vía de terminación fue vaginal en seis casos y abdominal en los doce restantes. Un embarazo se encuentra en evolución al momento de la presente comunicación
Subject(s)
Humans , Female , Pregnancy , Abortion, Habitual/therapy , Autoimmunity/drug effects , Fetal Growth Retardation/therapy , Platelet Aggregation Inhibitors/therapeutic use , Abortion, Habitual/physiopathology , Antibodies, Antiphospholipid , Aspirin/therapeutic use , Infertility/physiopathologyABSTRACT
Objetivo: Describir los resultados del tratamiento anti-agregante plaquetario en un grupo de pacientes con auto-anticuerpos y antecedentes de aborto recurrente (AR) y/o retardo de crecimiento intrauterino (RCIU). Material y Métodos: Diecisiete pacientes que consultaron por AR y/o RCIU, mala historia obstétrica o antecedentes de VDRL falso positivo, en cuyo estudio inmunológico se detectaron autoanticuerpos, constituyen el material del presente trabajo. A las pacientes que tenían como antecedente un RCIU, una vez descartados todos los cuadros clínicos que pudieran ocasionarlo, se les efectuó determinación de anticuerpos. Las parejas que consultaban por AR eran sometidas a estudio para descartar un factor uterino, infeccioso, endocrinológico, metabólico, genético, innmunológico y espermático. En algunas pacientes se realizó una laparoscopia para descartar endometriosis. Todas las pacientes fueron tratadas con Acido Acetilsalicílico (AAS) 80 mg diarios, a partir del momento de la detección de autoanticuerpos. A una sola paciente se le administró además heparina subcutánea durante dos embarazos. Resultados: De las diecisiete pacientes en las que se detectaron autoanticuerpos, catorce embarazaron, algunas de ellas en más de una oportunidad, sumando un total de 24 embarazos. De ellos, 5 concluyeron en aborto espontáneo y dieciocho concluyeron en el tercer trimestre con recién nacido vivo. De éstos, siete presentaron un crecimiento fetal normal, mientras que los once restantes desarrollaron RCIU. La vía de terminación fue vaginal en seis casos y abdominal en los doce restantes. Un embarazo se encuentra en evolución al momento de la presente comunicación (AU)
Subject(s)
Humans , Female , Pregnancy , Abortion, Habitual/therapy , Autoimmunity/drug effects , Fetal Growth Retardation/therapy , Platelet Aggregation Inhibitors/therapeutic use , Aspirin/therapeutic use , Antibodies, Antiphospholipid/drug effects , Infertility/physiopathology , Abortion, Habitual/physiopathologyABSTRACT
Obstetricians' epidemiological knowledge and their awareness of associated risk factors are essential for the primary prevention of birth defects. Screening and early diagnosis of congenital malformations is an expanding field in general obstetrics. Cardiac defects are the most frequent type of congenital malformation, and early detection is possible.